HealthStream (HSTM) Competitors

HealthStream (NASDAQ:HSTM) and Omnicell (NASDAQ:OMCL) are both small-cap health care technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

Which has more risk & volatility, HSTM or OMCL?

HealthStream has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500.

Do analysts prefer HSTM or OMCL?

HealthStream currently has a consensus target price of $31.00, suggesting a potential upside of 17.10%. Omnicell has a consensus target price of $46.71, suggesting a potential upside of 46.55%. Given Omnicell's higher possible upside, analysts plainly believe Omnicell is more favorable than HealthStream.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthStream	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Omnicell	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

Which has preferable valuation & earnings, HSTM or OMCL?

HealthStream has higher earnings, but lower revenue than Omnicell. HealthStream is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthStream	$291.65M	2.69	$20.01M	$0.67	39.51
Omnicell	$1.11B	1.32	$12.53M	$0.50	63.75

Does the media prefer HSTM or OMCL?

In the previous week, HealthStream had 1 more articles in the media than Omnicell. MarketBeat recorded 11 mentions for HealthStream and 10 mentions for Omnicell. HealthStream's average media sentiment score of 0.92 beat Omnicell's score of 0.48 indicating that HealthStream is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthStream	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omnicell	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals have more ownership in HSTM or OMCL?

69.6% of HealthStream shares are held by institutional investors. Comparatively, 97.7% of Omnicell shares are held by institutional investors. 20.5% of HealthStream shares are held by company insiders. Comparatively, 2.5% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is HSTM or OMCL more profitable?

HealthStream has a net margin of 6.89% compared to Omnicell's net margin of 2.01%. HealthStream's return on equity of 5.70% beat Omnicell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthStream	6.89%	5.70%	3.99%
Omnicell	2.01%	4.27%	2.44%

Summary

HealthStream beats Omnicell on 11 of the 17 factors compared between the two stocks.